Credit Suisse Ag Procept Bio Robotics Corp Transaction History
Credit Suisse Ag
- $101 Billion
- Q1 2024
A detailed history of Credit Suisse Ag transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Credit Suisse Ag holds 55,407 shares of PRCT stock, worth $3.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,407
Previous 53,966
2.67%
Holding current value
$3.5 Million
Previous $2.26 Million
21.1%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$337 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$268 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$208 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$186 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$125 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.82B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...